Gotowe bibliografie tematyczne / HIV (Viruses) Gene therapy / Książki

Książki na temat „HIV (Viruses) Gene therapy”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: HIV (Viruses) Gene therapy.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 1 lutego 2022

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „HIV (Viruses) Gene therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Bauer, Gerhard, i Joseph S. Anderson. Gene Therapy for HIV. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0434-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Vos, Jean-Michel H., red. Viruses in Human Gene Therapy. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0555-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Singwi, Sanjeev. HIV gene therapy using nucleases. Ottawa: National Library of Canada, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Smith, Clay. Gene Therapy for HIV Infection. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-11821-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Hengge, Ulrich R. Immunotreatment and gene therapy of HIV infection. Bremen: Uni-Med, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Berkhout, Ben, Hildegund C. J. Ertl i Marc S. Weinberg, red. Gene Therapy for HIV and Chronic Infections. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2432-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Virology, Conference on. HIV and other highly pathogenic viruses. San Diego: Academic Press, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Canada, Canada Health and Welfare. Therapy and management of CMV in patients with HIV infection/ by Susan M.King. Ottawa: Health and Welfare Canada, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Lombardi, Rocco Anthony. GAG and ENV trans-dominant mutants for use in ANTI-HIV-1 gene therapy. Ottawa: National Library of Canada, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Mindel, Adrian. AIDS: A pocket book of diagnosis and management. Wyd. 2. London: Arnold, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Brambilla, Riccardo. Viral vector approaches in neurobiology and brain diseases. New York: Humana Press, 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

International Washington Spring Symposium (10th 1990 George Washington University). Advances in molecular biology and targeted treatment for AIDS. New York: Plenum Press, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Tokyo Institute of Psychiatry. International Symposium. Cutting edge medicine and liaison psychiatry: Psychiatric problems of organ transplantation, cancer, HIV/AIDS, and genetic therapy : proceedings of the 13th Tokyo Institute of Psychiatry International Symposium held in Tokyo on 29-30 September 1998. Redaktorzy Matsushita Masaaki 1937- i Fukunishi Isao. Amsterdam: Elsevier, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Juelg, Boris, i Rajesh Gandhi. HIV Cure Strategies. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
Although current antiretroviral therapy (ART) is highly effective at controlling HIV-1 replication, it does not eradicate or cure the infection. HIV-1 persists quiescently in cellular reservoirs, not detected by the immune system due to the lack of active viral replication; these reservoirs represent the major obstacle for cure approaches. Reversal of HIV-1 latency and induction of virus expression by a variety of interventions may render infected cells susceptible to immune recognition and active clearance. Strategies to boost immune responses via vaccination, immunomodulation, or gene therapy are being evaluated with the aim of achieving HIV-1 control without antiretroviral therapy, if not viral eradication.
17

H, Vos Jean-Michel, red. Viruses in human gene therapy. Durham, N.C: Carolina Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Naicker, Saraladevi, i Graham Paget. HIV and renal disease. Redaktor Vivekanand Jha. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0187_update_001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
The human immunodeficiency virus (HIV) infection epidemic has particularly affected the poorest regions of the world. HIV can directly or indirectly affect different aspects of renal function, and results in a variable expression of kidney disease.Acute kidney injury (AKI) occurs in approximately 20% of hospitalized patients. The prevalence of chronic kidney disease (CKD) amongst HIV-infected patients is reported at 3.5–38% in different regions of the world. The complex interplay between the pheno- and/or genotypic variants of the virus, the genetic make-up of the host, and environmental factors determine the clinical manifestations of renal disease. The association of APOL1 gene variants G1 and G2 with the risk of focal segmental glomerulosclerosis explains the high frequency of HIV-associated nephropathy (HIVAN) in populations of black ethnicity.Anti-retroviral therapy (ART) is effective in preventing progression of HIVAN. Some of the drugs used in ART regimens are potentially nephrotoxic and require dose adjustment or even avoidance in CKD. Progression to end-stage renal disease (ESRD) in HIVAN has been reported to correlate with the extent of chronic damage quantified by renal biopsy.HIV-infected patients requiring dialysis, who are stable on ART, are achieving survival rates comparable to those of non-HIV dialysis populations. Similarly, HIV infection does not seem to adversely affect patient and graft survival rates after kidney transplantation, and there has been no increase in the prevalence of opportunistic infections in transplant recipients on effective ART.
19

Gene therapy for HIV infection. Georgetown, Tex: R.G. Landes, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Ian, Phillips M., red. Gene therapy methods. San Diego, Calif: Academic Press, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Berkhout, Ben, Hildegund C. J. Ertl i Marc S. Weinberg. Gene Therapy for HIV and Chronic Infections. Springer, 2015.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Sax, Paul E., Calvin J. Cohen i Daniel R. Kuritzkes. HIV Essentials 2010. Jones & Bartlett Learning, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Cid-Arregui, Angel. Viral Vectors: Basic Science and Gene Therapy. EATON PUBLISHING, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Biloshytsky, Vadym, i Roman Cregg. Pioneering use of gene therapy for pain. Redaktorzy Paul Farquhar-Smith, Pierre Beaulieu i Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0083.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
The landmark paper discussed in this chapter is ‘Gene therapy for pain: Results of a Phase I clinical trial’, published by Fink et al. in 2011. In this study, the first of its kind, researchers studied the efficacy and safety of a modified herpes simplex virus (HSV) vector used to deliver PENK, which encodes proenkephalin, which is cleaved into the enkephalin peptides Met-enkephalin and Leu-enkephalin, which induce analgesia by acting on opioid receptors. The development of the HSV vector was based in part on results studies in which adenovirus, adeno-associated virus, or non-viral vectors were used to overexpress genes. Overexpression of a variety of large molecules leads to a reduction in pain-related behaviour in animals. Gene therapy in the treatment of chronic pain seems to offer a promising alternative to systemic or highly invasive therapies. However, additional research is needed to determine the safety, effectiveness, and cost-efficiency of this approach.
25

(Editor), Jacqueline D. Reeves, i Cynthia A. Derdeyn (Editor), red. Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy) (Milestones in Drug Therapy). Birkhäuser Basel, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

A, Haseltine William, Wong-Staal Flossie i Harvard AIDS Institute, red. Genetic structure and regulation of HIV. New York: Raven Press, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Bauer, Gerhard, i Joseph S. Anderson. Gene Therapy for HIV: From Inception to a Possible Cure. Springer, 2014.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Robert, Franza B., Cullen Bryan i Wong-Staal Flossie, red. The Control of human retrovirus gene expression. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

1958-, Harrington Kevin J., Pandha Hardev i Vile Richard G, red. Viral therapy of cancer. Chichester, West Sussex, England: John Wiley & Sons, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Harrington, K. J. Viral Therapy of Cancer. John Wiley & Sons, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

(Editor), P. R. Lowenstein, i L. W. Enquist (Editor), red. Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. John Wiley & Sons, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

R, Lowenstein P., i Enquist L. W, red. Protocols for gene transfer in neuroscience: Towards gene therapy of neurological disorders. Chichester: J. Wiley & Sons, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Emini, Emilio. The Human Immunodeficiency Virus: Biology, Immunology, and Therapy. Princeton University Press, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

The Human immunodeficiency virus: Biology, immunology, and therapy. Princeton, N.J: Princeton University Press, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

A, Machida Curtis, red. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

A, Machida Curtis, red. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

A, Machida Curtis, red. Viral vectors for gene therapy: Methods and protocols. Totowa, New Jersey: Humana Press, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Medina, Maria Fe C. Strategies for isolation and expression of ribozymes for use in HIV gene therapy. 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

(Editor), Michael G. Kaplitt, i Arthur D. Loewy (Editor), red. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

G, Kaplitt Michael, i Loewy Arthur D, red. Viral vectors: Gene therapy and neuroscience applications. San Diego: Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

(Editor), Michael G. Kaplitt, i Arthur D. Loewy (Editor), red. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

(Editor), Michael G. Kaplitt, i Arthur D. Loewy (Editor), red. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

(Editor), Boro Dropulic, i Barrie Carter (Editor), red. Concepts in Genetic Medicine. Wiley, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Concepts in genetic medicine. Hoboken, N.J: John Wiley & Sons, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Machida, Curtis A. Viral Vectors for Gene Therapy: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Ramezani, Ali. Development and testing of mono- and multimeric hammerhead ribozymes for HIV-1 gene therapy. 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

G, Giraldo, red. Development and applications of vaccines and gene therapy in AIDS. Basel: Karger, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „HIV (Viruses) Gene therapy” dla innych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie

Do bibliografii